Millican-Slater Rebecca, Good Rona, Nash Claire, Heads Judith A, Pollock Steven, Chalkley Rebecca, Gomm Jenny, Jones J Louise, Sundara-Rajan Sreekumar, Horgan Kieran, Hanby Andrew M, Speirs Valerie
Department of Histopathology and Molecular Pathology, St James's Institute of Oncology, St James's University Hospital, Leeds, UK.
Cell Tissue Bank. 2015 Mar;16(1):27-34. doi: 10.1007/s10561-014-9444-y. Epub 2014 Apr 9.
Biobanks provide a window of opportunity to store and add value to material from rare cases allowing their future use in biomedical research. One such example is the opportunityto obtain good quality tissue from patients undergoing gender re-assignment. Following patient agreement to donate tissue samples to our biobank we catalogued the histological appearance, defined the expression of the hormone receptors ERα, PR, AR and the proliferation marker Ki67, and generated and characterised primary cell cultures in a female to male (FTM) transgender patient referred to our unit for surgery. Immunohistochemistry was performed for ERα, PR and AR and the proliferation marker Ki67. Hormone receptor expression was confined to epithelial cells lining the breast ducts. Ki67 immunoreactivity was sparse indicating little proliferation of luminal epithelium, consistent with normal mammary gland. Cultures of epithelial cells and fibroblasts were derived from surplus tissue. The latter lacked expression of epithelial markers and hormone receptors but exhibited expression of vimentin. Culture of the former on Matrigel saw an outgrowth of more rounded "epithelial-like" cells. Immunofluoresence characterisation showed a mixed phenotype with expression of vimentin and both myoepithelial and luminal epithelial markers. Sporadic weak ERα expression and moderate PR expression was seen. In summary, as well as routinely collecting tissue and blood samples, we have characterised and stored tissue and cells from a FTM transgender patient, adding value to this resource which,available from the Breast Cancer Campaign Tissue Bank for those interested in further studying the biology of FTM transgender tissue.
生物样本库提供了一个机会之窗,可用于存储罕见病例的材料并为其增值,以便未来用于生物医学研究。一个这样的例子是有机会从接受性别重置手术的患者身上获取高质量的组织。在患者同意将组织样本捐赠给我们的生物样本库后,我们对组织学外观进行了编目,确定了激素受体ERα、PR、AR以及增殖标志物Ki67的表达,并在一名转诊至我们科室进行手术的女性转男性(FTM)跨性别患者中建立并鉴定了原代细胞培养物。对ERα、PR、AR以及增殖标志物Ki67进行了免疫组织化学检测。激素受体表达局限于乳腺导管内衬的上皮细胞。Ki67免疫反应性稀少,表明管腔上皮细胞增殖很少,这与正常乳腺一致。上皮细胞和成纤维细胞培养物源自多余的组织。后者缺乏上皮标志物和激素受体的表达,但表达波形蛋白。将前者培养在基质胶上,可见更多圆形的“上皮样”细胞生长。免疫荧光鉴定显示其具有混合表型,表达波形蛋白以及肌上皮和管腔上皮标志物。可见散在的弱ERα表达和中度PR表达。总之,除了常规收集组织和血液样本外,我们还对一名FTM跨性别患者的组织和细胞进行了鉴定和存储,为这一资源增添了价值,有兴趣进一步研究FTM跨性别组织生物学的人可从乳腺癌运动组织库获取该资源。